— Know what they know.
Not Investment Advice

ALVIO.PA PAR

Valerio Therapeutics S.A.
1W: -9.1% 1M: -26.2% 3M: +10.7% YTD: +225.2% 1Y: +731.7% 3Y: +98.0%
€0.51 ($0.57)
-0.02 (-3.78%)
 
Weekly Expected Move ±6.9%
€0 €0 €1 €1 €1
PAR · Healthcare · Biotechnology · Tech Score Sell · Power 39 · €254.2M mcap · 408M float · 0.378% daily turnover

Balance Sheet Trends

Total Assets
$18M -49.2% ▼
5Y CAGR: -13.8%
Total Liabilities
$26M +28.0% ▲
5Y CAGR: +5.1%
Shareholders Equity
-$9M -160.3% ▼
Cash & Investments
$1M -82.7% ▼
5Y CAGR: -27.1%
Total Debt
$13M +49.3% ▲
5Y CAGR: +9.4%
Net Debt
$12M +462.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$15M$18M$15M$7M$1M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$15M$18M$15M$7M$1M
Net Receivables$7M$9M$1M$2M$2M
Inventory$0$1M$744K$6K$0
Other Current Assets$2M$805K$3M$3M$1M
Total Current Assets$23M$30M$21M$13M$5M
Property, Plant & Equip.$3M$2M$2M$2M$1M
Goodwill & Intangibles$21M$21M$21M$21M$12M
Long-Term Investments$110K$37K$11K$145K$140K
Other Non-Current Assets$233K$162K$90K$74K$81K
Total Non-Current Assets$23M$23M$23M$22M$13M
Total Assets$47M$53M$43M$35M$18M
— Liabilities —
Accounts Payable$3M$3M$3M$2M$5M
Short-Term Debt$2M$3M$1M$1M$7M
Deferred Revenue$472K$214K$504K$0$0
Other Current Liabilities$23K$0$46K$6M$5M
Total Current Liabilities$6M$7M$7M$11M$18M
Long-Term Debt$2M$5M$8M$7M$6M
Other Non-Current Liab.$7M$6M$5M$2M$2M
Total Non-Current Liabilities$11M$13M$14M$9M$8M
Total Liabilities$17M$20M$21M$20M$26M
— Equity —
Common Stock$20M$23M$28M$39M$22M
Retained Earnings$1M-$6M-$20M-$20M-$46M
Accumulated OCI-$9M-$14M-$33M-$32M$0
Total Stockholders Equity$29M$33M$22M$15M-$9M
Total Liabilities & Equity$47M$53M$43M$35M$18M
— Key Metrics —
Total Debt$6M$10M$10M$9M$13M
Net Debt-$8M-$3M-$4M$2M$12M
Total Investments$110K$37K$11K$145K$140K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms